EastWest Bioscience Inc. (V:EAST*CA)

Business Focus: N/A

Jul 27, 2020 04:20 pm ET
IIROC Trading Resumption - EAST
VANCOUVER, BC, July 27, 2020 /CNW/ - Trading resumes in:
Jul 23, 2020 09:00 pm ET
Retraction & Correction of May 28, 2020 News Release
PENTICTON, BC / ACCESSWIRE / July 23, 2020 / EastWest Bioscience (the "Company" or "EastWest") (TSXV:EAST) reports that, on July 8, 2020, the US Securities and Exchange Commission (the "SEC") issued an order of suspension of trading in shares of EastWest traded on the US "over-the-counter" market (the "Order"). The Order referenced the accuracy and adequacy of information that was contained in the press release of EastWest distributed on May 28, 2020 regarding the U.S. Food and Drug Administration's (the &
Jul 09, 2020 10:07 am ET
IIROC Trading Halt - EAST
VANCOUVER, BC, July 9, 2020 /CNW/ - The following issues have been halted by IIROC:
Jun 30, 2020 09:50 am ET
EastWest Bioscience Reports Third Quarter Fiscal 2020 Financial Results
Key highlights of third quarter of 2020 fiscal year
Jun 25, 2020 09:15 am ET
EastWest Bioscience Announces Closing of Private Placement and Settlement of Debts for Shares
PENTICTON, BC / ACCESSWIRE / June 25, 2020 / EastWest Bioscience (the "Company" or "EastWest") (TSXV:EAST) is pleased to announce that further to the Company's press release dated June 18, 2020, the Company has closed a private placement financing with the issuance of 1,992,727 common shares at a price of $0.05 per common share for aggregate proceeds of $99,636.37. The private placement was subscribed by one investee Summit Bancorp. The proceeds from the private placement will be used for general corporate purposes. The common shares issued pursuant
Jun 18, 2020 01:55 pm ET
EastWest Bioscience Announces Private Placement
VANCOUVER, BC / ACCESSWIRE / June 18, 2020 / EastWest Bioscience (the "Company" or "EastWest") (TSXV:EAST) announces that it intends to conduct a private placement financing of up to 2,000,000 common shares at a price of $0.05 per common share for aggregate proceeds of up to $100,000. The proceeds from the private placement will be used for general corporate purposes.
Jun 15, 2020 09:00 am ET
EastWest Bioscience Announces Settlement of Debts for Shares
All of the common shares issued pursuant to these arrangements are subject to TSX Venture Exchange approval and a statutory four-month hold period in accordance with applicable securities laws.
Jun 02, 2020 09:25 am ET
EastWest Bioscience Receives Additional Health Canada Approval for Hand Sanitizer
PENTICTON, BC / ACCESSWIRE / June 2, 2020 / EastWest Bioscience's ("EastWest") (TSXV:EAST) manufacturing subsidiary, Orchard Vale Naturals ("Orchard Vale" or the "Company"), has received additional Health Canada approval for hand sanitizer. This will secure our supply of material required to meet the market demand.
May 28, 2020 10:30 am ET
EastWest Bioscience 80% Ethyl Alcohol Hand Sanitizer Receives FDA Approval
PENTICTON, BC / ACCESSWIRE / May 28, 2020 / EastWest Bioscience's ("EastWest") (TSXV:EAST) manufacturing subsidiary, Orchard Vale Naturals ("Orchard Vale" or the "Company"), has received U.S. Food and Drug Administration ("FDA") approval for its 80% ethyl alcohol hand sanitizer liquid spray. This will allow Orchard Vale to distribute its hand sanitizer to the American market, adding revenue streams to its US operation.
May 20, 2020 10:00 am ET
EastWest BioScience Supplement Manufacturing Division Expands Production to Meet Increased Demand During Pandemic
PENTICTON, BC / ACCESSWIRE / May 20, 2020 / EastWest Bioscience's ("EastWest") (TSXV:EAST) manufacturing subsidiary, Orchard Vale Naturals ("Orchard Vale"), has seen a substantial increase in its manufacturing orders due to surging demand for health and wellness products during the COVID-19 pandemic.
May 19, 2020 08:30 am ET
Hand Sanitizer Approval from Health Canada
PENTICTON, BC / ACCESSWIRE / May 19, 2020 / EastWest Bioscience's (the "Company" or "EastWest") (TSXV:EAST) subsidiary, Orchard Vale Naturals ("Orchard Vale"), has received Health Canada approval for hand sanitizer liquid spray.
Apr 29, 2020 07:06 pm ET
Early Warning Report in Accordance with National Instrument 62-103
Penticton, British Columbia--(Newsfile Corp. - April 29, 2020) -  Mr. Rodney Gelineau issues this press release pursuant to Part 3 - Early Warning Requirements of National Instrument 62-103 with respect to EastWest Bioscience Inc. ("EastWest").
Apr 02, 2020 12:40 pm ET
EASTWEST REPORTS IMPROVED FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL 2020
EastWest Bioscience Inc. (the “Company” or “EastWest”) (TSX.V: EAST) has released its second quarter results for the three months ending January 31, 2020. Financial results for the second quarter of 2020 The Company reported revenues for the...
Feb 11, 2020 08:20 pm ET
EastWest Files First Quarter 2020 Interim Financial Statements and Provides Update Regarding Management Cease-Trade Order
VANCOUVER, BC / ACCESSWIRE / February 11, 2020 / EastWest Bioscience Inc. ("EastWest" or the "Corporation") announces that it filed its interim financial statements for the three months ended October 31, 2019, related management discussion and analysis and applicable officer certificates (collectively, the "Quarter One Filings"). The Interim Filings can be accessed on the Company's SEDAR profile at www.sedar.com. The Corporation is now current on its continuous disclosure requirements.
Feb 06, 2020 08:00 am ET
Construction Completed on EastWest's Kentucky, USA CBD Processing and Bottling Line
LEBANON, KY / ACCRESSWIRE / February 6, 2020 / EastWest Bioscience (the "Company" or "EastWest") (TSXV:EAST) announces that, further to its News Release on November 27th, the Company is pleased to announce that construction is completed on its CBD processing and bottling line in Lebanon, Kentucky. The CBD manufacturing line is part of its 50/50 joint venture with Azema Sciences through its US division, EastWest Science USA ("EastWest USA").
Jan 31, 2020 06:55 pm ET
EastWest Files Audited 2019 Annual Financial Statements and Provides Fifth Status Report Regarding Management Cease-Trade Order
VANCOUVER, BC / ACCESSWIRE / January 31, 2020 / EastWest Bioscience Inc. (TSXV:EAST) ("EastWest" or the "Corporation") announces that it filed its annual consolidated financial statements for the year ended July 31, 2019, related management discussion and analysis and applicable officer certificates (collectively, the "Annual Filings"). The Annual Filings can be accessed on the Company's SEDAR profile at www.sedar.com.
Jan 23, 2020 08:40 pm ET
EastWest Issues Fourth Bi-Weekly Status Report Regarding Management Cease-Trade Order
VANCOUVER, BC / ACCESSWIRE / January 23, 2020 / EastWest Bioscience Inc. (TSXV:EAST) ("EastWest" or the "Corporation") provides this bi-weekly default status report in accordance with National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203"). In its initial default announcement of November 29, 2019 (the "Default Notice"), the Corporation announced the delay in the filing of its audited annual financial statements for the year ended July 31, 2019 (the "2019 Annual Financial Statements") and related manag
Jan 20, 2020 05:40 pm ET
EastWest Bioscience to Close Debt Settlement Arrangement
VANCOUVER, BC / ACCESSWIRE / January 20, 2020 / EastWest Bioscience Inc. (TSXV:EAST) ("EastWest" or the "Corporation") is pleased to announce it will be closing a debt settlement arrangement, subject to TSXV appproval.
Jan 09, 2020 09:20 pm ET
EastWest Issues Third Bi-weekly Status Report Regarding Management Cease-Trade Order
VANCOUVER, BC / ACCESSWIRE / January 9, 2020 / EastWest Bioscience Inc. (TSXV:EAST) ("EastWest" or the "Corporation") provides this bi-weekly default status report in accordance with National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203"). In its initial default announcement of November 29, 2019 (the "Default Notice"), the Corporation announced the delay in the filing of its audited annual financial statements for the year ended July 31, 2019 (the "2019 Annual Financial Statements") and related manage
Dec 27, 2019 09:00 pm ET
EastWest Issues Second Bi-Weekly Status Report Regarding Management Cease-Trade Order
VANCOUVER, BC / ACCESSWIRE / December 27, 2019 / EastWest Bioscience Inc. ("EastWest" or the "Corporation") provides this bi-weekly default status report in accordance with National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203"). In its initial default announcement of November 29, 2019 (the "Default Notice"), the Corporation announced the delay in the filing of its audited annual financial statements for the year ended July 31, 2019 (the "2019 Annual Financial Statements") and related management discu
Dec 18, 2019 09:00 pm ET
EastWest Bioscience to Acquire Shares of 1123573 BC Ltd. and Orchard Valley Naturals Ltd.
VANCOUVER, BC / ACCESSWIRE / December 18, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSXV:EAST) announces that it has entered a share purchase agreement (the "Agreement") with Darryl Sangster, Aquila Health Corp. and Sangster's Real Estate Corp. (collectively, the "Sangster Parties") for the purchase of shares of 1123573 BC Ltd. ("573") and Orchard Valley Naturals Inc. ("Valley"). Completion of the Agreement is subject to the approval of the TSX Venture Exchange.
Dec 12, 2019 08:10 pm ET
EastWest Issues Bi-Weekly Status Report Regarding Management Cease-Trade Order
VANCOUVER, BC / ACCESSWIRE / December 12, 2019 / Eastwest Bioscience Inc. ("Eastwest" or the "Corporation") provides this bi-weekly default status report in accordance with National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203"). In its initial default announcement of November 29, 2019 (the "Default Notice"), the Corporation announced the delay in the filing of its audited annual financial statements for the year ended July 31, 2019 (the "2019 Annual Financial Statements") and related management discu
Nov 29, 2019 03:00 pm ET
Default Announcement
VANCOUVER, BC / ACCESSWIRE / November 29, 2019 / Eastwest Bioscience Inc. ("Eastwest" or the "Corporation") provides this default announcement indicating Eastwest's anticipated failure to file its annual financial statements for the year ended July 31, 2019 and related management discussion and analysis and certifications (collectively, the "Financial Statements") before the prescribed filing deadlines.
Nov 27, 2019 10:30 am ET
EastWest Bioscience Continues Expansion into the US market with the Construction on its CBD Processing and Bottling Line Nearing Completion
LEBANON, KY / ACCESSWIRE / November 27, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSXV:EAST) announces that, further to its News Release on June 20th, the Company is pleased to announce that construction is nearing completion on its CBD processing and bottling line in Lebanon, Kentucky. The CBD manufacturing line is part of its 50/50 joint venture with Azema Sciences through its US division, EastWest Science USA ("EastWest USA") and is targeted to be completed by December 15, 2019.
Nov 06, 2019 12:44 pm ET
InnerScope Hearing Technologies Inc. (OTCQB: INND) Establishes a Distribution, Warehousing, and Manufacturing Agreement in Canada and the United States with EASTWEST BIOSCIENCE INC. (TSX.V: EAST)
EASTWEST BIOSCIENCE INC. and InnerScope Hearing Technologies Inc. have entered into an Agreement for both companies to establish distribution and marketing rights to include warehousing and distribution facilities based in Canada and the United States.
Nov 06, 2019 08:35 am ET
InnerScope Hearing Technologies (OTCQB: INND) Establishes a Distribution, Warehousing, and Manufacturing Agreement in Canada and the United States with EASTWEST BIOSCIENCE (TSX.V: EAST)  
via OTC PR WIRE -- InnerScope Hearing Technologies Inc. (OTCQB: INND) ("InnerScope") a manufacturer and Direct-to-Consumer ("DTC") distributor/retailer of FDA-Registered Hearing Aids, Personal Sound Amplifiers Products ("Hearing Products"), Hearing...
Oct 30, 2019 08:30 am ET
EastWest Bioscience Continues Expansion in US with Its First Production Run of CBD Pet Products
LEBANON, KN / ACCESSWIRE / October 30, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSXV:EAST) announces that, further to its News Release on July 23rd, the Company has completed the first production run of its CBD Pet Treats for the US Market. The premium CBD used in these CBD pet treats was supplied and produced through its joint venture partnership with Azema Sciences at its facility in Lebanon, Kentucky, USA.
Sep 20, 2019 11:09 am ET
IIROC Trading Resumption - EAST
VANCOUVER, Sept. 20, 2019 /CNW/ - Trading resumes in:
Sep 20, 2019 10:57 am ET
EastWest Comments on Trading Halt
CALGARY, AB / ACCESSWIRE / September 20, 2019 / EASTWEST BIOSCIENCE INC. (the "Corporation") (TSXV:EAST) announces that it halted trading in its common shares on Monday morning as it was negotiating a material agreement with an arm's length third party. The negotiated event did not materialize and therefore trading in its common shares will resume later today.
Sep 16, 2019 07:50 am ET
IIROC Trading Halt - EAST
VANCOUVER, Sept. 16, 2019 /CNW/ - The following issues have been halted by IIROC:
Sep 10, 2019 10:47 am ET
EastWest Bioscience Signs Distribution and Broker Deal with Rise North America Based in the United States
VANCOUVER, BC / ACCESSWIRE / September 10, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSXV: EAST) announces that it has signed a distribution and broker agreement with RISE North America (“RISE NA”) headquartered in Annapolis, MD. RISE NA’s team brings over 100 years of collective retail sales, distribution, and broker experience with great success launching and growing new products in some of the largest chains in the United States. In addition, they operate a successful on-line store for products across many categories.
Sep 05, 2019 08:30 am ET
EastWest Science USA secures supply of organic CBD
VANCOUVER, BC / ACCESSWIRE / September 5, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSX.V:EAST) announces that its joint venture partner Azema Sciences Inc’s (Azema) subsidiary KYBG, Inc. has signed a definitive joint venture agreement with a local Kentucky organic hemp propagator and broker to form Kentucky Extraction and Processing, LLC (KEP).
Aug 15, 2019 10:46 am ET
EastWest Bioscience to Enter the People's Republic of China with Its Full Line of Hemp-Based Products
VANCOUVER, BC / ACCESSWIRE / August 15, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSXV:EAST) announces that it is in the final stages of obtaining it’s Business License to sell products into the People’s Republic of China through a strategic new partnership with Diverse Global Service (DGS), based in Chengdu Area of China (Sichuan) Pilot Free Trade Zone, who are both EastWest’s consultants and brokers. Chengdu has a diverse economy highlighting the food industry, IT and automotive manufacturing. It is one of the most important economic centers in Western China.
Aug 01, 2019 08:30 am ET
EastWest Bioscience Signs Letter of Intent with Pet Tonics.
VANCOUVER, BC / ACCESSWIRE / August 1, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) has signed an LOI with Pet Tonics, LLC, DBA Paws Effect (“Paws”), located in Coppell, TX USA (pawseffect.com). Partnering with strong brands is a significant part of EastWest’s overall strategy to ensure a larger footprint in the retail landscape in Canada, the USA, and Asia. Pet Tonics’ current produ
Jul 24, 2019 06:45 pm ET
EastWest Bioscience Announces Grant of Stock Options
VANCOUVER, BC / ACCESSWIRE / July 24, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) announces that it has granted stock options (“Options”) to acquire up to 3,792,500 common shares of the Company, 1,125,000 of which were granted to directors and officers of the Company. Each of the Options vested immediately, are exercisable for a five-year term, expiring in 2024 and exercisable at a price of $0.15 per common share. On the last day that the Company's common shares
Jul 23, 2019 08:30 am ET
EastWest USA Received First Batch of Full Spectrum CBD Oil from Azema Sciences for CBD Pet Treats
VANCOUVER, BC / ACCESSWIRE / July 23, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) announces that, further to its News Releases on April 26th and June 25th, 2019, that the Company has received the first batch of its Full Spectrum CBD Oil for its initial pet orders for the US Market from its preferred supply and distribution Joint Ventu
Jul 04, 2019 08:30 am ET
EastWest Bioscience Reports Third Quarter 2019 Financial Results
VANCOUVER, BC / ACCESSWIRE / July 4, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands on its vision, strategy, and outlook for the future and comments on its 3Q financial results for the three months ended April 30, 2019.
Jun 27, 2019 08:30 am ET
EastWest Science USA Signs Mutual US Distribution Agreement with CBD Manufacturer GM Health Wholesale
VANCOUVER, BC / ACCESSWIRE / June 27, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that its subsidiary EastWest Science USA has signed a mutual distributor agreement with GM Health Wholesale ("GM Health") (www.gmhempco.com), a Kentucky company and a leading manufacturer and wholesaler of CBD Tinctures, Creams, Salves and Capsules. Under the terms of this agreement GM Health will become a distributor of EastWest's products and EastWest will become a global distributor for GM Health's all-natural
Jun 25, 2019 08:30 am ET
EastWest Bioscience Starts Production of CBD Pet Treats for the US Market
VANCOUVER, BC / ACCESSWIRE / June 25, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that, further to its News Release on April 26th, 2019, that the Company has started production of CBD infused Chill Dog and Quick Cat for the US Market.
Jun 24, 2019 08:30 am ET
EastWest Bioscience Continues Expansion in Western Canada Through Avafina Pet Products
VANCOUVER, BC / ACCESSWIRE / June 24, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that it has partnered with Avafina Pet Products ("Avafina") (www.avafinapet.com) to distribute its Natural Pet Science line of pet treats into more than 300 stores across Western Canada. Avafina's passionate and knowledgeable sales professionals, along with their distribution centre in Coquitlam, BC, provides a strategic distribution and sales partnership into the independen
Jun 20, 2019 08:30 am ET
EastWest Bioscience Signs Definitive Joint Venture Agreement with Azema Sciences; US Expansion Story Continues
VANCOUVER, BC / ACCESSWIRE / June 20, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that, further to its News Release on April 30th, 2019 that the Company has signed a Definitive Agreement with Azema Sciences Inc. ("Azema" or "Azema Sciences") to Joint Venture on a preferred supply and distribution agreement, specifically for the supply of bulk CBD and finished CBD products, and distribution throughout the US and Globally.
Jun 19, 2019 08:30 am ET
DTC Application Update: EastWest Bioscience Passes Due Diligence for FINRA Form 15c-211
VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that, further to its News Release on May 7th 2019, it has passed third party due diligence pursuant to FINRA Rule 15c2‐11 ("Form 211"), as part of the Company's DTC application. Form 211 clearance is important as it requires the Directors and Principals of EAST, in addition to the Company itself to pass the regulatory background checks and due diligence necessary to list in the U.S. Form 211 clearance opens the way for EAST to com
Jun 18, 2019 08:30 am ET
EastWest Bioscience Continues Global Expansion Through a Distribution Agreement with New Zealand Hemp Brokers
VANCOUVER, BC / ACCESSWIRE / June 18, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX-V: EAST) announces that it has signed a distributor agreement with New Zealand Hemp Brokers (NZHB) (www.nzhempbrokers.com), a leading wholesaler and New Zealand's only specialist Hemp Broker with reach into important key markets in New Zealand, Australia, and Asia. NZHB are experts in the distribution, import and export of industrial hemp (iHemp) and hemp products. EastWest will begin shipping Earth's Menu, Natural
Jun 12, 2019 09:00 am ET
EastWest Bioscience Receives TSX Approval for Operations in 20 Additional US States.
VANCOUVER, BC / ACCESSWIRE / June 12, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands into 20 Additional US States with TSX approval.
Jun 10, 2019 10:00 am ET
EastWest Bioscience signs Letter of Intent with Benchmark Botanics
VANCOUVER, BC / ACCESSWIRE / June 10, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that it has signed a Letter of Intent for a J oint V enture with Benchmark Botanics Inc. ("Benchmark") (CSE: BBT) for the purposes of Cannabis Act licensing, joint product development, and product distribution to national and international markets. EastWest and Benchmark are excited to be aligning their Canadian businesses across multiple stages of the product lifecycle.
May 16, 2019 08:30 am ET
EastWest Bioscience Signs Letter of Intent to Joint Venture with Continental Agro Trade Corporation a Canadian Industrial Hemp Grower
VANCOUVER, BC / ACCESSWIRE / May 15, 2019 / EastWest Bioscience (the "Company"or "EastWest") (TSX.V: EAST) announces that on May 13, 2019 they signed a Letter of Intent to joint venture with Continental Agro Trade Corporation ("Continental") to secure a ready stockpile of Hemp flower containing CBD for EastWest's production of high-grade CBD isolate. This stockpiled Hemp supply will be ready for processing into CBD isolate within Eastwest's Penticton Facility immediately upon approval for Eastwest's Cannabis Processor license.
May 14, 2019 02:00 pm ET
EastWest Bioscience Contracts Internal Investor Relations Representative
VANCOUVER, BC / ACCESSWIRE / May 14, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) advises that on February 1, 2019 the Company contracted Mr. Nicholas Vincent, located in Penticton BC and operating as 1149677 B.C. Ltd. (the "Consultant") for the role of internal Investor Relations manager.
May 07, 2019 09:25 am ET
EastWest Bioscience Inc. Announces Submission of DTC and OTCQB Venture Market Applications
VANCOUVER, BC / ACCESSWIRE / May 7, 2019 / EastWest BioScience Inc. ("Company" or "EastWest") (TSXV: EAST) announces its eligibility to The Depository Trust Company ("DTC") for trading its shares on the OTC Market has been established and subsequently the Company has submitted all required applications. In parallel, the Company has submitted its application for the OTCQB Venture Market and expects to be listed on that important US and international securities exchange in the near future.
Apr 30, 2019 10:10 am ET
EastWest Bioscience Signs Joint Venture Intent with US CBD Manufacturer Azema Sciences Inc.
VANCOUVER, BC / ACCESSWIRE / April 30, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) announces that on April 29, 2019 they signed an LOI with Azema Sciences Inc. ("Azema" or "Azema Sciences") to Joint Venture on a preferred supply and distribution agreement for bulk CBD and finished CBD products throughout the US and Globally.
Apr 26, 2019 08:30 am ET
EastWest Bioscience Adds to CBD Pet Product Line and Leverages FDA Green Light on Hemp Seed in the USA
VANCOUVER, BC / ACCESSWIRE / April 26, 2019 / EastWest Bioscience (the "Company"or "EastWest") (TSX.V: EAST) announces four additional products to its Natural Pet Science line, both in Canada and the USA, with CBD included in the USA destined products and which will be marketed to CBD permitted jurisdictions.
Apr 17, 2019 08:30 am ET
EastWest Bioscience Incorporates US Company in Kentucky for US Operations and CBD Product Development
VANCOUVER, BC / ACCESSWIRE / April 17, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) is moving rapidly on the recent TSX-V approval allowing EastWest to operate in the USA and announces today its incorporation of EastWest Science USA (EastWest USA), a wholly owned operational subsidiary focussed on CBD consumer products, manufacturing, production and distribution based in Marion County Kentucky, the heart of hemp growing and processing in the USA.
Apr 15, 2019 08:30 am ET
EastWest Bioscience Restructures its Board for Expansion into the US and EU CBD Markets
VANCOUVER, BC / ACCESSWIRE / April 15, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) announces today the appointment of two new independent Directors, Paul Mandl and Jeff Bierman, to the Board. Both these new board members will help to ensure the Company is well-equipped to efficiently execute its expansion into the US and EU. Scott Reeves, previously Chair of Board, is voluntarily stepping into the role of Secretary. Douglas Horne, who served as an independent on the Company's board since March 2017 has resigned from the board for
Apr 10, 2019 09:00 am ET
EastWest Bioscience Receives TSX Approval for Operations in Kentucky, USA with Eight New CBD Products
VANCOUVER, BC / ACCESSWIRE / April 10, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands into Kentucky, USA with TSX approval.
Apr 08, 2019 09:00 am ET
EastWest Comments on 2Q Financial Statements and Expands on Vision, Strategy, and Execution
VANCOUVER, BC / ACCESSWIRE / April 8, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands on its vision, strategy, and outlook for the future and comments on its 2Q financial results for the three months ended January 31, 2019.
Apr 03, 2019 08:20 pm ET
EastWest Announces Completion of Unit Offering
VANCOUVER BC / ACCESSWIRE / April 3, 2019 / Vancouver, BC: EASTWEST BIOSCIENCE INC. (the "Corporation")(TSXV: EAST) today announced that it is has completed the sale of2,283,168 units of the Corporation ("Units") at aprice of $0.15 per Unit for aggregate gross proceeds of $342,475.Each Unit consists of one common share in the capital of theCorporation ("Common Share") and one-half of oneshare purchase warrant, with each whole warrant("Warrant") entitling the holder there
Mar 28, 2019 11:00 am ET
A Message from the CEO - EastWest's Corporate Update on its Vision, Strategy, and Execution
VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX-V: EAST) President and CEO Rodney Gelineau gives a corporate update.
Mar 07, 2019 12:41 pm ET
EastWest Bioscience Receives First Scheduled Purchase Order from Major Pet Products Distributor Natural Pet Distributors
VANCOUVER, BC / ACCESSWIRE / March 7, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX-V: EAST) has received its first order from Natural Pet Distributors ("NPD") (www.naturalpetdistributors.com) one of its major eastern Canadian pet distribution partners. In accordance with its overall execution strategy to increase retail distribution of its family of products in 2019, Natural Pet Distributors provides a significant partnership for EastWest providing distribution into independent and majo
Mar 01, 2019 12:25 pm ET
EastWest Bioscience Receives New PO’s from Global Retailer the TJX Companies Inc to Increase Canada Wide Distribution
VANCOUVER, BC / ACCESSWIRE / March 1, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX-V: EAST) announces that the Company has received several new purchase orders for its hemp-based consumer goods from global retailer The TJX Companies, Inc (NYSE: TJX), the leading mass retailer of apparel and home fashions in the U.S. and worldwide.
Feb 22, 2019 08:30 am ET
EastWest Bioscience Attends CHFA West Natural Health Product Show to Introduce its Newest Hemp-based Food and Body Care Products
VANCOUVER. BC / ACCESSWIRE / February 22, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces it will be attending the Canadian Health Foods Association (CHFA) West Tradeshow at the Vancouver Convention Centre in Vancouver, BC on February 23rd - 24th from 10AM to 5PM at Exhibit #414. The Company will be featuring promos and taste samplings of their new Chewy Goodness Granola Bars which are available for purchase and in stores now under the Earth's Menu brand. Also being introduced is the Company's new HempBeauti Shampoo and Cond
Feb 19, 2019 08:15 pm ET
EastWest Announces Appointment of New Chief Operating Officer
VANCOUVER, BC / ACCESSWIRE / February 19, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSXV: EAST) is pleased to announce that Ms. Ciska Asriel has been appointed Chief Operating Officer of the Company. Ms. Asriel has degrees in Economics, Finance and Computer Science with an MBA in International Business. Before joining EastWest as a Co-Founder and Chief Operating Officer, Ms. Asriel worked as consultant, senior analyst and project manager for small companies as well as major firms including Deloitte. Her
Feb 13, 2019 08:30 am ET
EastWest Bioscience Manufactures HempBeauti Shampoo and Conditioner under the Company's ChenvreHemp Body Care Brand
VANCOUVER, BC / ACCESSWIRE / February 13, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces the manufacturing of the first two products of its newest line of hemp-based products being introduced in 2019. The Company's HempBeauti Shampoo and Conditioner is the first of a series of premium ultra-clean body care products under the ChenvreHemp brand line. HempBeauti Shampoo and Conditioner are due to be in stores late April or early May 2019.
Feb 07, 2019 08:30 am ET
EastWest Bioscience Ships Its New Line of Delicious Hemp and Fruit Snack Bars under Its growing Earth's Menu Brand
VANCOUVER, BC / ACCESSWIRE / February 7, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces the first shipment this week of its premium granola-style hemp seed and fruit snack bars under its Earth's Menu food product brand. Chewy Goodness, Unapologetically Delicious snack bars have been formulated in three delicious and nutritious flavours - Omega Apple, Omega Cranberry and Blueberry Raisin - all Kosher and Peanut free. The first products are shipping into Eastwest's two warehouse facilities this week with reta
Jan 31, 2019 06:50 pm ET
EastWest Announces $1,000,000 Non-Brokered Private Placement
Not for Distribution to U.S. Newswire Services or for Dissemination in the United States. Any Failure to Comply with This Restriction May Constitute a Violation of U.S. Securities Laws.
Jan 29, 2019 09:00 am ET
EastWest Bioscience Ships its First Natural Pet Science Brand of Hemp and Cricket Treats to Mondou, Quebec's Largest Pet Store Chain
VANCOUVER, BC / ACCESSWIRE / January 29, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces its initial shipment this week of its premium pet brand Natural Pet Science available for purchase at Mondou, Quebec's largest pet retail chain. Mondou is an important part of Eastwest's overall sales strategy to expand its retail distribution across Canada and into Quebec, Canada's second largest province. As per the purchase agreement between EastWest and Mondou, Natural Pet Science's unique hemp and cricket focused pet treats will be
Jan 24, 2019 09:00 am ET
EastWest is Executing Its Long-Term US Hemp Strategy
VANCOUVER, BC / ACCESSWIRE / January 24, 2019 / EastWest Bioscience (the "Company"or "EastWest") (TSX.V: EAST) is excited that the federal legalization of hemp in the US with the final passage of the US Farm Bill has opened significant opportunities for EastWest. It can now follow through on its long-held strategy to acquire assets, produce, and market hemp products to the 50 States and beyond.
Jan 21, 2019 09:00 am ET
EastWest Bioscience Opens Additional Corporate Owned Sangster's Health Center at Boutique Country Hills Mall in Calgary
VANCOUVER, BC / ACCESSWIRE / January 21, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that it has completed the fifth of the five planned Sangster's Health Center Stores converted from a franchise owned to a corporate owned store. The Sangster's Country Hills Mall Store at 450 Country Hills Blvd, NE, Calgary Alberta will re-open tomorrow, January 22nd, 2019 at 10AM MST. Country Hills Mall is a boutique mall located one of Calgary's newer communities The mall conveys an air of urban sophistication and reta
Jan 17, 2019 08:30 am ET
Financial Markets Updated with Market Discussions about Eastwest Science's Build-out Strategy
VANCOUVER, BC / ACCESSWIRE / January 17, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX.V: EAST) announces the publication of two important market news items that help explain the strategic positioning and strengths of Eastwest's build-out strategy to investors and the financial markets.
Jan 14, 2019 08:00 am ET
EastWest Bioscience Opens Sangster's Health Center at Marlborough Mall in Calgary as a Corporate Store
VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / January 14, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that it has completed the fourth of the five planned Sangster's Health Center Stores where are to be converted from a franchise store to a corporate store. The Sangster's Marlborough Mall Store at 433 Marlborough Way N.E. in Calgary, Alberta will re-open today, January 14th, 2019 at 10 AM MST. An official Grand Opening event for this store and additional new corporate
Jan 10, 2019 10:01 am ET
EastWest Bioscience Expands Its’ Pet Products Distribution Through Natural Pet Distributors
VANCOUVER, BC / ACCESSWIRE / January 10, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that it has partnered with Natural Pet Distributors ("NPD") (www.naturalpetdistributors.com) with reach into 550 stores in Southern Ontario and Quebec. Natural Pet Distributors provides a unique strategic partnership with Eastwest for successful introduction and long-term sales of its products into both the independent and major pet chain channels. With NPD's centrally lo
Jan 09, 2019 09:00 am ET
EastWest Announces Appointment of New Chief Financial Officer
VANCOUVER, BC / ACCESSWIRE / January 9, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX-V: EAST) is pleased to announce that Mr. Paul Marjerrison, B. Comm., CPA, CA, has been appointed Chief Financial Officer of the Company. In 2018, Mr. Marjerrison assisted EastWest with its acquisition of Sangster's Health Centres, including pre-closing diligence, the purchase and sale agreement, and post-closing integration, as well as financial planning, analysis and reporting for EastWest. Since 2015, Mr. Marjerrison
Jan 08, 2019 08:59 am ET
EastWest Bioscience Inc. Announces Application for DTC Eligibility and United States OTC Market Quote
VANCOUVER, BC / ACCESSWIRE / January 8, 2019 / Eastwest BioScience Inc. ("Company" or "Eastwest") (TSX-V: EAST) announces it has engaged a consultant to apply for eligibility to The Depository Trust Company ("DTC") to allow for the trading of the Company's shares on the OTC Market. The Depository Trust Company (DTC), a subsidiary of the Depository Trust & Clearing Corporation DTCC, manages the electronic clearing and settlement of publicly traded companies. Securities eligible to be electronically cleared and
Jan 03, 2019 09:00 am ET
EastWest Bioscience Appoints High Profile Retail Management Advisory Team
VANCOUVER, BC / ACCESSWIRE / January 3, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) announces the appointment of an exceptional team of retail advisors effective January 1, 2019, an active retail advisory board (the "Advisory") to help with the next stage development of EastWest's retail model, product development, and the recently acquired Sangster's Health Centres ("Sangster's").
Dec 19, 2018 09:00 am ET
Passage of U.S. Farm Bill a Major Milestone for EastWest’s Long Term Hemp Strategy
EastWest BioScience Negotiating Major Strategic Hemp and CBD Opportunities.
Dec 13, 2018 09:00 am ET
Eastwest BioScience Receives Multiple Purchase Orders with Global Retailer The TJX Companies Inc (NYSE: TJX) for Canada Wide Distribution
VANCOUVER, BC / ACCESSWIRE / December 13, 2018 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that the Company is processing purchasing orders for its hemp based consumer goods through global retailer The TJX Companies, Inc (NYSE:TJX), the leading mass retailer of apparel and home fashions in the U.S. and worldwide. TJX is a global retail giant that has built a distinguishable and competitive brand with a strong foothold in Canada's consumer goods market under the banner TJX Canada, which comprises popular home
Dec 11, 2018 04:40 pm ET
EastWest Announces Change of Directors
VANCOUVER, BC / ACCESSWIRE / December 11, 2018 / EastWestBioscience (formerly HarbourStar Capital Inc.) (the "Company" or"EastWest") (TSXV: EAST) announces that Mr. Mohammad Fazil has resigned as a director effectiveas of December 4, 2018, the Company wishes to thank Mr. Fazil for his years ofservice to Harbour Star Capital Inc. and assistance following completion of the qualifying transaction, asset out in the press release issued by the Company on July 23, 2018.
Dec 06, 2018 09:00 am ET
EastWest Bioscience Closes Acquisition of Sangster's Health Centres, a National Canadian Natural Health Retail Chain
VANCOUVER, BC / ACCESSWIRE / December 6, 2018 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX-V: EAST) is pleased to announce the closing of the Company's previously announced acquisition (the "Acquisition") of the iconic chain of 29 Sangster's Health Centres ("Sangster's") on November 30th, 2018. Sangster's is one of Canada's most storied national natural health product franchises. The acquisition gives EastWest a strategic footprint in its quest to become the leading hemp-focused consumer goods company in
Dec 05, 2018 01:35 pm ET
EastWest Bioscience Continues Expansion on the Canadian East Coast Through Agreement with Largest Pet Chain in Quebec
VANCOUVER, BC / ACCESSWIRE / December 5, 2018 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) announces that it will soon have its premium pet brand Natural Pet Science available for purchase at Mondou, the largest pet retail chain in Quebec. Having the Natural Pet Science products available at Mondou is within Eastwest's overall sales strategy to expand its retail distribution across Canada toward the country's East Coast including French-speaking Quebec, Canada's largest province. The Company has developed its French language marketing a
Nov 28, 2018 05:05 pm ET
Harbour Star Capital Inc. Announces Name Change to EastWest Bioscience Inc.
VANCOUVER, BC / ACCESSWIRE / November 28, 2018 / Harbour Star Capital Inc. (the "Company") (TSXV: EAST) is pleased to announce that it has changed its name to EastWest Bioscience Inc. The Company's stock trading symbol on the TSX Venture Exchange will remain as EAST. The Company will commence trading under its new name at the opening of trading on Friday, November 30, 2018. The Company is not subdividing, consolidating or otherwise altering its share capital in association with the name change.
Nov 26, 2018 09:05 am ET
Eastwest Partners with CrossDock Systems for Product Warehousing and Shipping Solutions
EastWest continues expansion across Canada, partnering with one of Canada's fastest growing full-service logistics solutions provider for Eastern Canadian distribution
Nov 22, 2018 09:00 am ET
EastWest Converts Three Sangster’s Franchise Stores into Corporate Stores Including Plans for Pharmacies
EastWest Continues Building its Footprint for Health Product Distribution Across Canada
Nov 19, 2018 09:00 am ET
Harbour Star Capital Holds Special and Annual General Meeting to Approve Directors and Corporate Name Change
Not for Distribution to U.S. Newswire Services or for Dissemination in the United States
Nov 13, 2018 09:45 am ET
IIROC Trading Resumption - EAST
VANCOUVER, Nov. 13, 2018 /CNW/ - Trading resumes in:
Nov 13, 2018 09:00 am ET
EastWest Bioscience Signs Agreement to Acquire National Canadian Natural Health Retail Store Chain
VANCOUVER, BC / ACCESSWIRE / November 13, 2018 / Harbour Star Capital Inc. dba EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) is pleased to announce its pending acquisition (the "Acquisition") of the iconic chain of 28 Sangster's Health Centres ("Sangster's"). Sangster's is one of Canada's most storied national natural health product franchises. Its acquisition gives EastWest a strategic advantage in becoming the leading hemp focused consumer goods compa
Nov 05, 2018 08:18 am ET
IIROC Trading Halt - EAST
VANCOUVER, Nov. 5, 2018 /CNW/ - The following issues have been halted by IIROC:
Oct 25, 2018 10:36 am ET
EastWest Developing CBD Infused Products Under New Industrial Hemp Exemption
VANCOUVER, BC / ACCESSWIRE / October 25, 2018 / Harbour Star Capital Corp. dba EastWest BioScience (TSX-V: EAST) ("EastWest" or the "Company") comments today on the benefits to EastWest of Health Canada's October 17th implementation of the Subsection 56(1) Class Exemption in relation to the Company's use of hemp under Industrial Hemp regulations (flowering heads, leaves and branches).
Oct 17, 2018 09:00 am ET
Harbour Star Capital Inc. to change name to EastWest Bioscience Inc.
VANCOUVER, BC / ACCESSWIRE / October 17, 2018 / Harbour Star Capital Corp. dba EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces it will be holding its Annual and Special Shareholders Meeting on November 9, 2018 at which it plans to change its name from "Harbour Star Capital Inc." to "Eastwest BioScience Inc.".
Oct 10, 2018 09:00 am ET
EastWest Bioscience Pushes Boundaries to Expand into Cannabis and CBD
Vancouver, British Columbia (FSCwire) - Harbour Star Capital Corp. dba EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) announces it has engaged Phytosciences Consulting LLC. (“Phytosciences”), a US-based consulting firm with an array of cannabis expertise ranging from laboratory design, specification, and setup to pharmaceutical product design, testing, and manufacturing.
Oct 04, 2018 03:57 pm ET
Eastwest BioScience Closes Private Placement.
Calgary, Alberta (FSCwire) - Harbour Star Capital Corp. dba Eastwest BioScience Inc (TSXV:EAST) (“Eastwest” or the “Company“) is pleased to announce it has closed the offering of a non-brokered private placement of $730,925.25 in units ("Units") announced October 3, 2018, subject to TSXV approval.
Oct 03, 2018 09:00 am ET
Eastwest BioScience Announces Private Placement and Changes to the Board of Directors
Vancouver, British Columbia (FSCwire) - Harbour Star Capital Corp. dba Eastwest BioScience Inc (TSXV:EAST) (“Eastwest” or the “Company“) is pleased to announce the offering of a non-brokered private placement of $800,000 in units ("Units").  There is no minimum subscription for this offering and a maximum of 2,909,090 Units will be issued at a price of $0.275 per Unit.  Each Unit will consist of one common share in the capital of the Company (a "Common Share") and one-half of one common share purchase warrant (a "Warrant"). Each whole Warrant would entitle the holder to purchase one additional Common Share at an exercise price of $0.50 for a period of one year from the date of issuance of the Warrant.  In addition, the Warrants will be subject to an acceleration clause whereby if, following the Closing Date, the 10-day volume weight average trading price of the Common Shares of the Corporation on the principal market on which such shares trade is equal to or exceeds CDN$0.75 (with the 10th such trading date hereafter referred to as the "Eligible Acceleration Date"), the Warrant expiry date shall accelerate to the date which is 30 calendar days following the date a press release is issued by the Corporation announcing the reduced warrant term, provided, no more than five business days following the Eligible Acceleration Date: (i) the press release is issued; and (ii) notices are sent to all warrant holders.
Sep 27, 2018 09:00 am ET
EastWest Bioscience’s Hemp Pet Brand Processes Second Major Purchase Order with Global Manufacturer to Fulfill Product Demand
Vancouver, British Columbia (FSCwire) - Harbour Star Capital Corp. dba EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) is pleased to announce that the Company is processing its second purchasing order (or “PO”) for its premium pet brand Natural Pet Science through global manufacturer Rolf C. Hagen, Inc. The second PO follows the brand’s first successful run after its well-received product release in July and signifies the Company’s continued growth as it forges a path as a leader in the natural pet foods market.
Sep 18, 2018 09:53 am ET
Eastwest Bioscience Expanding Three Brandlines through Distribution Network of 2,000 Retail Stores Nationwide
Vancouver, British Columbia (FSCwire) - Harbour Star Capital Corp. dba EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) is announcing its partnership with M² Brand Management, Inc. (“MSquared” or “M2”) a full-service brand management firm engaged to broker distribution of Eastwest’s three major premium hemp brands: Natural Advancement, Natural Pet Science, and Earth’s Menu. M² Brand Management is a national full-service brand management firm, specializing in sales and marketing strategies for leading natural & organic brands. The distribution agreement will introduce the Company’s products to the shelves of over 2,000 retail stores across Canada.
Sep 12, 2018 09:47 am ET
EastWest Will Attend Canada’s Largest Natural Food Product and Pet Product Trade Shows in Toronto in September
Vancouver, British Columbia (FSCwire) - Harbour Star Capital Corp dba EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) is pleased to announce that it will be a presenter at the  Canadian Health Food Association (“CHFA”) and the Pet Industry Joint Advisory Council of Canada (“PIJAC”) trade shows this year, being held from Sept. 15 to Sept. 16 and Sept. 16 to Sept. 17 respectively in Toronto, Ontario. Both trade shows are highly-anticipated industry events among manufacturers, retailers and distributors in the fields of natural health foods and pet products. The tradeshows provide EastWest with the opportunity to showcase their brands of premium hemp products directly to potential customers and commercial trade partners. The Company will have exhibits showcasing the Company’s multiple brands of premium hemp health products at CHFA West 2018 and it will offer the latest product innovations of its’ premium pet brand at PIJAC’s 2018 national pet trade show.
Sep 07, 2018 09:00 am ET
Canadian Brand Natural Pet Science New Product Launch Receives Media Recognition for Pet Treats Made from Hemp and Crickets
Vancouver, British Columbia (FSCwire) - Harbour Star Capital Inc. (dba) EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) is announcing the Company’s release of its premium pet brandline Natural Pet Science, a unique line of health-conscious pet treats infused with hemp and other innovative ingredients such as Canadian-farmed high-quality, very high-protein crickets. The initial product launch features two of the Vancouver-based brand’s innovative pet treats: Slim’Dog, with a weight control formula for dogs, and Calm’Cat, with a calming formula for cats. Both pet treat formulas bolster a rich supply of protein and Omega-6 and Omega-3 fatty acids tailored specifically for dogs and cats. The forward-thinking brand aims to provide consumers with healthy and sustainably produced pet product options.
Aug 30, 2018 09:00 am ET
EastWest Bioscience’s Consumer Goods Division Launches New Innovative Food Brand Earth’s Menu with Nationwide Distribution
Vancouver, British Columbia (FSCwire) - EastWest Bioscience Group (the “Company” or “EastWest”) (TSX.V: EAST) is excited to announce the Company’s launch of its innovative hemp food brand Earth’s Menu, with the brand’s premiere whole hemp product Hemp Harmony Hemp Seeds. Hemp Harmony Hemp Seeds uses hemp that is locally-sourced in British Columbia and will kick-off an extensive range of hemp-based healthy food products under the Earth’s Menu brand. The launch is a significant milestone as it cements the Vancouver-based brand as one of the very few food companies to offer a wide-selection of food products focused on hemp, providing the Company with a defining leader status in the rapidly-growing natural foods market and hemp industry.
Aug 27, 2018 04:10 pm ET
EastWest Bioscience Announces Engagement of Business Consultants and Option Grant
Vancouver, British Columbia (FSCwire) - EastWest BioScience Group (the “Company” or “EastWest”) (TSX.V: EAST) is excited to announce the engagement of two Ontario based business consulting firms for the provision of services related to sourcing business development opportunities, strategic, marketing, financial and business plans, access to capital and related matters.  The consultants will be engaged on a month to month basis and will be granted an aggregate 975,000 options to acquire common shares of the Company, each such option being exercisable at a price of C$0.15 per common share for a two-year term expiring on August 26, 2018. The stock options will vest over a 9 month period with 25% vested immediately and a further 25% on each of the subsequent 3 month periods. The stock options, and any common shares issued upon exercise of the stock options, are subject to a four-month hold period expiring on December 27, 2018.
Aug 14, 2018 09:00 am ET
EastWest Bioscience Secures Distribution Deal to Access 7,000+ Stores Nationwide
Vancouver, British Columbia (FSCwire) - EastWest BioScience Group (the “Company” or “EastWest”) (TSX.V: EAST) is excited to announce that Natural Pet Science, its premium pet brand division, has secured a distribution agreement with Purity Life Health Products LP (“Purity Life”) that distributes high-quality natural healthy living products to a vast network of over 7,000 stores nationwide. Purity Life, Canada’s largest natural health product distributor, has selected pet treats, Slim’Dog and Calm’Cat, both of which contain a ground-breaking hemp and cricket-based formula for pets, as the first pet treats to be carried under the Purity Life banner, now available in warehouses for shipping.
Aug 08, 2018 03:17 pm ET
Hemp-Based Consumer Goods Company Harbour Star Capital (dba EastWest Bioscience) Announces Listing on TSX-V Under Symbol “EAST” with Future Expansion Plans in the CBD and the Cannabis Industry
Vancouver, Canada (FSCwire) - Harbour Star Capital Inc. (dba EastWest Science) (TSXV:EAST) announces the successful merger between the company and Harbour Star Capital to become EastWest Bioscience, which is officially listed on the TSX Venture Exchange (the “TSX-V”) under the trading symbol “EAST”. The listing has been in effect since July 26, 2018. It is a significant step toward the company’s vision to expand its premium hemp business worldwide. 
Jul 24, 2018 04:12 pm ET
IIROC Trading Resumption - BMET; EAST
VANCOUVER, July 24, 2018 /CNW/ - Trading resumes in:

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.